Email updates

Keep up to date with the latest news and content from Journal of Foot and Ankle Research and BioMed Central.

This article is part of the supplement: Proceedings of the Society of Chiropodists and Podiatrists Annual Conference 2010

Open Access Poster presentation

Autologous Blood Injection Therapy for tendinopathy

Olga Frankowski

  • Correspondence: Olga Frankowski

Author Affiliations

University of Salford, Salford, Greater Manchester, UK

Journal of Foot and Ankle Research 2010, 3(Suppl 1):P11  doi:10.1186/1757-1146-3-S1-P11

The electronic version of this article is the complete one and can be found online at: http://www.jfootankleres.com/content/3/S1/P11


Published:20 December 2010

© 2010 Frankowski; licensee BioMed Central Ltd.

This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Introduction

The aim of this poster is to provide a rationale and critical overview of ‘Autologous Blood Injection Therapy’ a new and possibly superior treatment modality in the management of tendinopathy. The theoretical background will be appraised including its clinical application and perceived clinical effectiveness.

Methods

literature review and critical appraisal of papers

Results

Autologous blood injection therapy has been shown to have a significant positive effect on both pain and joint function, with concomitant therapies not being demonstrated to be required in the management of tendinopathy. However, the majority of studies were representative of patients being treated for refractory epicondylitis with different procedure techniques being employed. No studies compared blood re-injection therapy with dry needling alone, with minimal data available from controlled studies preventing a placebo response from being ruled out.

Discussion

With current evidence on the efficacy of autologous blood injection therapy in the management of tendinopathy being insufficient in quantity and quality, the current National Institute for Health and Clinical Excellence guidelines state this procedure is to only be used with special arrangement. Future research should focus on randomised control trials that clearly describe previous or adjunctive therapeutic interventions with a minimum follow up of 1 year.